Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Safety and Efficacy Analysis of Oral Etoposide Combined With Anlotinib and Envafolimab in First-line Treatment of Elderly Patients With Small Cell Lung Cancer/ Open-label, Single-arm, Exploratory Phase II Clinical Study [Phase 2]
This open-label, single-arm Phase II trial evaluates the safety and potential efficacy of combining oral etoposide with Anlotinib and Envafo…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of MGC026 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for MGC026 in participants with advanced solid tumors; study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 ) [Phase 1, Phase 2]
A phase 1/2 clinical trial of radiopharmaceutical 225Ac-SS0110 in extensive-stage small cell lung cancer and Merkel cell carcinoma has been …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer [EARLY_Phase 1]
This document reports an early-stage Phase 1 trial at UNC evaluating autologous CAR T-cells targeting the GD2 antigen for lung cancer, with …
-
CLINICAL_TRIALS withdrawal · 2026-02-04Clinical Trial Update: Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy [Phase 2]
A Phase 2 trial of toripalimab for limited-stage small cell lung cancer after chemoradiotherapy has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients [Phase 2]
A Phase 2 clinical trial is evaluating tarlatamab as maintenance therapy after chemo-radiotherapy in patients with limited-stage small cell …
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone [Phase 2]
A Phase 2 clinical trial investigates maintenance therapy with Adebrelimab for localized small cell lung cancer after induction chemo with A…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Lung Cancer Screening in Population Who Had Never Smoked [NA]
A clinical trial update describing a study on lung cancer screening in people who have never smoked; the trial is not yet recruiting.
-
CLINICAL_TRIALS other · 2026-01-29Clinical Trial Update: Expanded Access to ABBV-706
An expanded access program for ABBV-706 in small cell lung cancer has been made available to eligible patients.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction [Phase 2]
Phase II, prospective, single-arm trial evaluating irinotecan liposome injection with platinum, immune checkpoint inhibitors, and anlotinib …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating BL-B01D1 in patients with metastatic or unresectable non-small cell lung cancer and other solid tumors is …
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating chemo-immunotherapy plus thoracic radiotherapy for extensive-stage small-cell lung cancer has been terminated.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) [Phase 2]
A prospective, single-arm Phase II trial is evaluating the safety and efficacy of adding chidamide to a PD-L1 inhibitor, carboplatin, and et…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors [Phase 1]
Phase 1 dose-finding study evaluating safety, tolerability, and pharmacokinetics of SNB-101 (SN-38) in patients with colorectal, breast, pan…
-
EMA approval · 2026-01-26EMA Authorised: Tevimbra (tislelizumab) — Beone Medicines Ireland Limited
EMA authorised Tevimbra (tislelizumab) from Beone Medicines Ireland Limited for multiple cancer indications, including esophageal squamous c…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients [Phase 1]
Phase 1 study of NEUK203-13 in refractory neuroendocrine tumors and extensive-stage small cell lung cancer reports safety, tolerability and …
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial evaluating adverse events and disease activity changes with ABBV-706 versus standard of care in adults with relapse…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: SLV-154 Treatment of Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for SLV-154 evaluating treatment of metastatic solid tumors. The study is currently recruiting across multiple…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer [Phase 1, Phase 2]
IDEAYA Biosciences is conducting a Phase 1/2 trial of IDE849 in DLL3-expressing tumors, including small cell lung cancer and neuroendocrine …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating bemotuzumab with chemotherapy and anlotinib induction followed by consolidative thoracic radiotherapy for …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD [Phase 2]
This Phase 2 clinical trial investigates post-concurrent chemoradiotherapy treatment strategies for limited-stage small cell lung cancer gui…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients [NA]
A prospective, longitudinal biocollection in thoracic oncology enrolling newly diagnosed lung cancer patients to collect biological samples …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia
This AstraZeneca-sponsored clinical trial assesses chemo-radiation therapy patterns and short-term outcomes in routine practice for unresect…
-
EMA approval · 2026-01-20EMA Authorised: Hycamtin (topotecan) — Sandoz Pharmaceuticals d.d.
EMA authorised Hycamtin (topotecan) by Sandoz Pharmaceuticals d.d. for the treatment of ovarian cancer, cervical cancer, and small cell lung…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma [Phase 1]
Phase I clinical trial update for an investigational carbonic anhydrase inhibitor in combination with radiochemotherapy or radioimmunotherap…